Best-in-class
anticancer
drug

HLB研发的Rivocerenib追求Best-in-class
Rivoceranib为针对癌症优秀的靶向药物

Leader of Global
Pharma

HLB navigates the way to the future by developing
First-in-class drugs with continuous innovation and challenges.